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Purpose: Hyperglycemia and hypertension contribute to the development of diabetic retinopathy, and this may involve
alterations in the normal retinal cell cycle. In this work, we examined the influence of diabetes and hypertension on retinal
cell replication in vivo and the relationship between these changes and several early markers of diabetic retinopathy.
Methods: Diabetes was induced with streptozotocin in 4- and 12-week-old spontaneously hypertensive rats (SHR) and
their Wistar Kyoto (WKY) controls. The rats were killed 15 days later. Retinal cells stained with bromodeoxyuridine
(BrdU) were seen in rats of both ages.
Results: In 12-week-old rats, the number of BrdU-positive retinal cells was higher in SHR than in WKY rats. After 15
days of diabetes mellitus, there was a marked reduction in cell replication only in diabetic SHR (p=0.007). The BrdU-
positive cells expressed neural, glial, or vascular progenitor markers. There was greater expression of p27Kip1 in the
ganglion cell layer of both diabetic groups (p=0.05), whereas in the inner nuclear layer there was enhanced expression
only in diabetic SHR (p=0.02). There was a marked increase in the retinal expression of fibronectin (p=0.04) and vascular
endothelial growth factor (p=0.02) in diabetic SHR that was accompanied by blood-retinal barrier breakdown (p=0.01).
Discussion: Concomitant diabetes and hypertension attenuated the proliferation of retinal cells, and it is associated with
an increase in p27Kip1 expression, fibronectin accumulation, and blood-retinal barrier breakdown. The replicative retinal
cells displayed characteristics of progenitor cells.
Diabetic retinopathy is a progressive neurologic disease
that is characterized by neuronal degeneration and extensive
vascular  changes.  However,  our  knowledge  of  the
mechanisms  leading  to  neuronal  cell  loss  and  vascular
dysfunction in diabetic retinopathy is still incomplete. We do
know  cells  other  than  endothelial  cells  and  pericytes  are
affected by hyperglycemia in diabetes [1,2]. Clinical studies
[3-8]  have  shown  that  hyperglycemia  causes  neural
dysfunction  in  the  retina  before  the  onset  of  diabetic
microvasculopathy.
The development of retinal disease varies among patients
with diabetes. Although hypertension may be an important
contributor, the precise mechanism by which hypertension
can exacerbate diabetic retinopathy remains to be established.
Diabetic individuals frequently have concomitant retinopathy
and  nephropathy,  and  it  has  been  suggested  that  similar
mechanisms  may  be  involved  in  these  two  long-term
complications of diabetes [9]. Inhibitors of cyclin-dependent
kinases (Cdk) such as p27Kip1, a negative cell cycle regulator,
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are involved in the development of diabetic nephropathy, with
associated mesangial hypertrophy and extracellular matrix
accumulation  [10-13].  In  addition,  genetic  hypertension
potentiates  the  cell-cycle  abnormalities  induced  by  renal
hyperglycemia [14]. These findings suggest that cell cycle
regulators are altered by the diabetic milieu and that such
alterations  contribute  to  the  pathogenesis  of  diabetic
microvascular complications.
The  early  phase  of  diabetic  retinopathy  involves
microangiopathy  characterized  by  a  diffuse  increase  in
vascular  permeability  and  capillary  basement  membrane
thickening [15-18]. Fibronectin, a component of the basement
membrane, is overexpressed in the retina of diabetic adults
[15].  Experimental  studies  have  indicated  that  this
accumulation  of  fibronectin  in  retinal  tissue  is  simply  an
epiphenomenon of the diabetic state, but may be operative in
sight-threatening  diabetic  retinopathy.  Indeed,  the
downregulation of fibronectin production in galactose-fed rats
partly prevented retinal basement membrane thickening and
reduced pericyte and endothelial cell loss [19].
The developing and postnatal vertebrate retina contains
neural progenitor cells that divide, generate neurospheres, and
undergo neuronal and glial differentiation [20-23]. These cells
can be identified by their ability to proliferate based on the
incorporation  of  bromodeoxyuridine  (BrdU),  and  by  the
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1680expression of progenitor markers such as nestin, membrane
receptor tyrosine kinase, also designated vascular endothelial
growth factor receptor-2 (Flk-1), and paired box gene 6 (Pax6)
[24-27]. p27Kip1 has recently been implicated in the molecular
mechanism that controls the decision of multipotent central
nervous system progenitors to withdraw from the cell cycle
and to maintain the differentiated state of the postmitotic cell
[28]. In the retina, p27Kip1 is expressed in a pattern coincident
with the onset of the differentiation of most retinal cell types,
and  in  vitro  the  accumulation  of  p27Kip1  in  retinal  cells
correlates  with  cell  cycle  withdrawal  and  differentiation,
thereby inhibiting progenitor cell proliferation [28].
These observations prompted us to search for potential
progenitor cells in adult rat retina. We also wanted to assess
the impact of hypertension and short-term diabetes on the
number of retinal BrdU positive cells and to examine the
relationship  between  these  cells  and  the  well  known
abnormalities  associated  with  the  early  stages  of  diabetic
retinopathy.  We  have  identified  a  small  population  of
potential progenitor cells characterized by BrdU positivity
that colocalize with nestin, protein kinase C-alpha (PKC-α),
Flk-1, and glial fibrillary acidic protein (GFAP) antigens.
Furthermore, the higher number of 84 proliferating cells in the
retina of adult spontaneously hypertensive rats compared with
normotensive rats was 85 significantly reduced in diabetic
SHR  rats.  These  findings  were  associated  with  enhanced
expression of p27Kip1 and with the classic abnormalities of
diabetic  retina—i.e.,  fibronectin  accumulation,  increased
expression  of  retinal  vascular  endothelial  growth  factor
(VEGF), and blood-retinal barrier breakdown.
METHODS
The experiments were done in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research.  The  protocol  for  this  study  complies  with  the
guidelines  of  the  Brazilian  College  for  Animal
Experimentation  (COBEA)  and  was  approved  by  the
institutional  Committee  for  Ethics  in  Animal  Research
(CEEA/IB/UNICAMP, protocol no. 1408–1). This study used
spontaneously hypertensive rats (SHR) and their genetically
normotensive counterparts, Wistar Kyoto rats (WKY), which
were  derived  from  animals  supplied  by  Taconic
(Germantown, NY) and bred in our animal facility. The rats
were housed at a constant temperature (24 °C) on a 12 h:12 h
light-dark cycle with access to food and tap water ad libitum.
The rats were weighed on the day before the induction of
diabetes and before they were euthanized.
Experimental diabetes was induced in 4- and 12-week-
old hypertensive male SHR and WKY rats, who had been
allowed to fast overnight. Each animal was given a single
intravenous  injection  of  50  mg/kg  streptozotocin  (STZ;
Sigma, St. Louis, MO), dissolved in sodium citrate buffer, pH
4.5, within 5 min of its preparation. Control rats received only
vehicle (500 μl citrate buffer). Blood glucose levels were
measured using an enzymatic colorimetric GOD-PAP assay
(Merck, Darmstadt, Germany) 72 h after the injection of STZ
or citrate buffer and on the day before euthanasia. Values ≥15
mmol/l were indicative of diabetes. Systolic blood pressure
was  obtained  by  tail-cuff  plethysmography  (Physiograph®
MK-III-S;  Narco  Bio-System,  Houston,  TX)  in
unanesthetized, warmed rats. Three to five determinations
were made per rat. Readings were taken on the day before the
induction of diabetes and before rats were euthanized. Rats
were habituated with the procedure for measurement before
taking the blood pressure readings.
Fifteen  days  after  the  induction  of  diabetes,  retinal
capillary  permeability  was  assessed,  and  the  rats  were
euthanized with an overdose (twice the anesthesic dose) of
anesthesia. The eye globes and retinas were collected for
immunohistochemistry,  immunofluorescence,  and  western
blot  analyses.  We  have  previously  described  early
inflammatory and oxidative changes in retina from diabetic
SHR rats after 20 days of diabetes mellitus [29,30]. The aim
of the present work was to examine the alterations in cellular
proliferation and apoptosis that precede the changes we have
mentioned, and to investigate the relationship between these
changes and the well established abnormalities associated
with the early stages of diabetic retinopathy.
Detection  of  proliferating  cells  in  vivo:  Retinal  cell
replication was evaluated based on the incorporation of BrdU
(Calbiochem,  La  Jolla,  CA),  a  thymidine  analog  that
incorporates into DNA in the S phase [14,31]. Briefly, the rats
were given an intraperitoneal injection of 100 mg/kg BrdU,
dissolved in saline, 1 h before they were euthanized. An equal
number of control rats received saline alone. The rats were
euthanized  with  an  intraperitoneal  injection  of  30  mg/kg
sodium  pentobarbital  (Hipnol,  Fontoveter,  Itapira,  SP,
Brazil). Their eyes were enucleated, and 130 a portion of the
gastrointestinal tract (positive control for BrdU staining) were
excised. The eye globe and the GI tract were 131 fixed in
buffered formalin, and embedded in paraffin-embedded, or
placed in OCT 132 cryoprotector (Tissue-Tech, Sakura, CA)
and snap frozen in liquid nitrogen for subsequent sectioning
in a cryostat. Next, 4 µm-thick consecutive sections were
mounted on silane-coated slides for immunofluorescence.
Immunohistochemistry for BrdU and p27Kip1: Detection
of BrdU and p27Kip1 was performed by dewaxing slides of eye
sections, rehydrating them, and placing in 2 N HCl at 31 °C
for 20 min and in 0.005% trypsin in phosphate-buffered saline
(PBS) at 37 °C for 2 min for antigen retrieval. After this
pretreatment, the slides were placed in 1% nonfat milk in PBS
for 1 h to block nonspecific sites. The sections were then
incubated with a 1:50 dilution of mouse antihuman antibodies
for BrdU (Dako, Glostrup, Denmark) or a 1:100 dilution of
mouse  monoclonal  anti-p27Kip1  antibody  (Transduction
Laboratories, Lexington, KY) for 1.5 h at room temperature.
The slides of eye sections were washed in, a biotinylated
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was applied and allowed to sit for 1 h. Endogenous peroxidase
was blocked by incubating the slides in 3% H2O2 for 5 min.
To detect p27Kip1, we performed microwave post-fixation of
slides immersed in 0.01 M citrate buffer, pH 6.0 using a
domestic  oven  (Panasonic  Junior,  Sao  Paulo,  SP,  Brazil)
operated at 700 W. The slides were incubated with an avidin-
biotin complex (ABC) reagent (Vector) for 30 min followed
by  the  addition  of  diaminobenzidine  tetrahydrochloride
(DAB; Sigma) as a substrate-chromogen solution. Next, the
slides were counterstained with hematoxylin before they were
dehydrated  and  mounted  in  Entellan  (Merck,  Darmstadt,
Germany). Positive controls for BrdU staining consisted of
sections of the gastrointestinal tract of each rat. Negative
controls for the reaction consisted of omitting the primary
antibody.
Quantitative analysis of BrdU positivity was done by an
observer unaware of the slide identification. The results were
expressed as the total number of positive cells counted in eight
random retinal sections from the right eye of each rat. For
p27Kip1, the results were expressed as a percentage of positive
cells in the ganglion cell and inner nuclear layers, using the
following scale: 0 (no positivity), 0.5 (up to 10% positivity),
1 (11%–25% positivity), 1.5 (26%–40% positivity), 2 (41%–
53%  positivity),  2.5  (54%–66%  positivity),  3  (67%–80%
positivity), and 4 (>80% positivity) [29]. The intervening
distance between retinal sections was approximately 24 μm.
Immunocolocalization  by  immunofluorescence:  The
slides were fixed with acetone for 3 min at room temperature,
after which they were washed with PBS, pH 7.4, and blocked
in PBS containing 5% bovine serum albumin (BSA) for 2 h
at room temperature. The sections were then incubated with
the appropriate primary antibody to identify glial, endothelial,
and neuronal cells (1:10 goat polyclonal anti-GFAP antibody;
Santa  Cruz  Biochemical,  Santa  Cruz,  CA;  1:100  mouse
monoclonal anti-FLK-1 antibody; Santa Cruz; 1:10 mouse
antinestin antibody; BD PharMingen™, Franklin Lakes, NJ;
and 1:10 mouse monoclonal anti PKC-α antibody; Abcam,
Inc., Cambridge, MA) for 5 h at room temperature. After they
were washed with PBS, the sections were incubated with
secondary  antibody  (donkey  antigoat  IgG-FITC  or  goat
antimouse  IgG-FITC)  as  appropriate  for  1  h  at  room
temperature.  The  slides  were  then  washed  with  PBS  and
incubated  with  1:10  sheep  polyclonal  anti-BrdU  antibody
(Abcam, Inc.) overnight at 4 °C, followed by another wash
with PBS and incubation with rabbit polyclonal antibody to
1:1,000 sheep IgG-rhodamine (1,5 mg of IgG; Abcam) for 1
h at room temperature. Finally, the sections were rinsed with
PBS then coverslipped with Vectashield antifading medium
containing  4',6'-diamino-2-phenylindole  (DAPI)  to  stain
nuclei (Vector). The sections were examined under a confocal
laser  scanning  microscope  (CLSM,  LSM510  Zeiss,  Jena,
Germany)  with  appropriate  emission  filters  for  FITC  and
rhodamine.  Digital  images  were  captured  using  specific
software (LSM; Zeiss). The negative controls consisted of
omitting the primary antibody.
Terminal  deoxynucleotidyl  transferase-mediated  nick-
end labeling: To determine whether retinal cell apoptosis was
influenced  by  age,  diabetes  or  rat  strain,  the  terminal
deoxynucleotidyl  transferase  (TdT)-mediated  dUTP-biotin
nick-end  labeling  (TUNEL)  method  for  detecting  DNA
breaks in situ [32] was applied to retinal tissue from the same
rats used for BrdU immunostaining. [14,32]. Sections (4 μm
thick) were deparaffinized, boiled in 0.01 M citric acid, pH
6.0, and incubated with 9.3 µg/ml proteinase K (Boehringer
Mannheim, Indianapolis, IN) for 15 min at room temperature.
Endogenous  peroxidase  was  quenched,  and  sections  were
rinsed  in  One-Phor-All  buffer  (Amersham  Pharmacia
Biotech, Piscataway, NJ), pH 7.2, and incubated with diluted
1:50  TdT  (Amersham  Pharmacia)  and  diluted  1:50
biotinylated-dUTP (Gibco, Grand Island, NY) in TdT buffer
(100 mM TRIS, 1 mM dithiothreitol, 50% of glycerol, 0.1%
sodium  azide,  0.01%,  Brij®35  [Polyoxyethyleneglycol
dodecyl  ether],  pH  7.2)  for  60  min  at  room  temperature.
Labeled nuclei were detected with ABC Vectastain (Vector)
in  PBS  and  DAB,  chloride,  and  hydrogen  peroxide  and
counterstained with hematoxylin. As a positive control, some
slides were treated with 20 Kunitz units/ml DNase (Sigma).
The quantitative analysis for TUNEL-positive cells was done
by an observer with no knowledge of the studied groups.
Results were expressed as the number of positive cells per
retinal section in at least eight random retinal sections from
the right eye of each animal. The distance between sections
was approximately 24 μm.
Isolation of retina: The eyes were enucleated, and the
retinas were dissected and isolated from the retinal pigmented
epithelium. The retinas were lysed directly on ice in 300 µl of
a buffer containing 2% SDS and 60 mM Tris-HCl (pH 6.8)
supplemented  with  a  cocktail  of  protease  inhibitors
(Complete®, containing irreversible and reversible protease
inhibitors such as antipain, aprotinin, bestatin, chymostatin,
Ethylenediaminetetraacetic  acid  (EDTA),  leupeptin,
pepstatin and phosphoramidon; Boehringer-Mannheim). The
lysed  retinas  were  centrifuged.  The  supernatants  were
transferred to new tubes, and the protein concentrations were
measured by the Bradford method [33], using BSA as the
standard.
Western blotting for fibronectin, GFAP, and VEGF: For
western blotting, 30 µg (for GFAP), 50 µg (for fibronectin),
and 100 µg (for VEGF) of total retinal protein in 5% glycerol/
0.03% bromophenol blue/10 mM dithiothreitol was loaded
onto 8%–15% SDS polyacrylamide gels. Molecular weight
markers  (Rainbow;  Amersham  Pharmacia)  were  used  as
standards. After electrophoresis, proteins were transferred to
nitrocellulose membranes (Bio-Rad, Hercules, CA) in transfer
buffer  consisting  of  50  mM  Tris-HCl,  pH  7.0,  380  mM
glycine, 0.1% SDS, and 20% methanol. Nonspecific binding
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1682was blocked by incubating the membranes overnight at 4 °C
in 5% nonfat milk, or at 4 °C in PBS containing 1% gelatin
with 0.1% Tween 20 (Fisher Chemicals, Fairlawn, NJ) for
VEGF. The membranes were then incubated for 1 h at room
temperature  with  primary  antibodies:  1:1,000  goat
monoclonal  anti-fibronectin  antibody  (Calbiochem,  San
Diego, CA), 1:100 polyclonal goat-GFAP antibody (Santa
Cruz, Santa Cruz, CA), and 1:5000 rabbit polyclonal IgG anti-
VEGF antibody (Santa Cruz). The blots were subsequently
washed in Tris-buffered saline with Tween and incubated with
horseradish  peroxidase  (HRP)-conjugated  secondary
antibody  (New  England  Biolabs,  Beverly,  MA).
Immunoreactive bands were visualized with the enhanced
chemiluminescence method (Super Signal CL-HRP Substrate
System; Pierce, Rockford, IL). Exposed films were scanned
with a densitometer (Bio-Rad) and analyzed quantitatively
with Multi-Analyst Macintosh Software for Image Analysis
Systems  Bio  Rad  (Hercules,  CA).  Western  blots  were
repeated 3–5 times; qualitatively similar results were obtained
each  time.  Equal  loading  and  transfer  was  ensured  by
reprobing the membranes for β-actin.
Quantitative  measurement  of  retinal  capillary
permeability using Evans blue dye: Briefly [34], the rats (SHR
and WKY) were anesthetized with an intraperitoneal injection
of 30 mg/kg sodium pentobarbital, and the left femoral vein
and  right  femoral  artery  were  cannulated  with  0.28  mm
internal  diameter  polyethylene  tubing  (Becton  Dickinson,
Sparks, MD) filled with heparinized saline (400 units heparin/
ml  saline).  Next,  45  mg/kg  Evans  blue  dye  was  injected
through the femoral vein over a period of 10 s. The blue color
of the rats confirmed the uptake and distribution of the dye.
Two minutes after the injection of the dye, 0.2 ml of blood
was drawn from the femoral artery to determine the initial
Evans blue plasma concentration. Subsequently, 0.1 ml of
blood was drawn from the femoral artery at 15 min intervals
for up to 2 h postinjection to obtain the time-averaged Evans
blue plasma concentration. Exactly 2 h after infusion, needle
was inserted into the left ventricle and the rats were perfused
for 2 minutes at 37°C with 0.05 M, pH 3.5, citrate-buffered
paraformaldehyde at a physiological pressure of 120 mm Hg.
Immediately after perfusion, both eyes were enucleated
and bisected at the equator. These animals were euthanized
with an injection of overdose of penthabarbitol. The retinas
Figure  1.  Immunohystochemistry  for
BrDU in retinal slides from studied rats.
The BrDU positive cells, although rare,
are localized in ganglion cell layer (A)
and in inner nuclear layer (B). The scale
bar represents 50 µm.
TABLE 1. GENERAL CHARACTERISTICS OF THE STUDIED RATS
Parameter
Younger rat groups Adult rat groups
CT-WKY DM-WKY CT-SHR DM-SHR CT-WKY DM-WKY CT-SHR DM-SHR
N 20 24 25 24 22 26 29 26
Final body weight
(g)
198±21 139±23† 134±15 105±12† 406± 54 293±43† 267±42 189±25†
Systolic blood
pressure (mmHg)
140 ±7‡ 142 ±5‡ 118±13 120±13 174±14‡ 174±18‡ 117±12 115±14
Glycemia (mmol/l) 6.9±0.3 30.4±2.5§ 7.1±0.5 28.6±4§ 6.2±1.3 25.6±5.2§ 5.8±1.6 25.3±4.2§
The following abbreviations are in effect: CT-WKY: control WKY; DM-WKY: diabetic WKY; CT-SHR: control SHR; DM-
SHR:  diabetic SHR; SBP: systolic blood pressure; * p<0.005 versus respectively WKY groups, † p<0.003 versus control groups,
‡ p=0.0001 versus WKY groups, § p<0.0001 versus control groups.
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1683Figure 2. Immunofuorescence assay for double labeling of BrDU positive cells in retinal sections against glial, neuron and endothelial markers.
In panel A, it is shown a retinal section showing two cells labeled for glial fibrillar acidic protein (GFAP) and BrdU in the ganglion cell layer.
In B, there are the presence of two BrdU-positive cells in outer nuclear layer of the retina co-stained with GFAP antibody. In this slide (C),
the BrDU positive cell is stained for nestin in the inner nuclear (long arrows) and ganglion cell (short arrows) layers of the retina. For
identification of amacrine/bipolar origin of BrDu positive cell in the retina, an immunofluorescence for PKC- α antigen was performed. There
is a BrDU positive cell that also stained for PKC- α in the outer nuclear (D). In panel E, elongated endothelial cells were identified expressing
both Flk-1 and BrdU, localized in theinner nuclear layer of the retina
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1684were carefully dissected under an operating microscope and
weighed.  They  were  then  dried  in  a  Speed-Vac  for
approximately 5 h. The Evans blue dye was extracted from
the tissue by incubating each retina in 120 µl formamide
(Sigma)  for  18  h  at  70  °C  followed  by  centrifugation  at
27,000x g for 45 min in a Beckman TLX rotor at 4 °C. The
absorbance of 60 μl aliquots of the supernatant was measured
spectrophotometrically in triplicate at A620 nm at 5 s intervals.
The absorbances were corrected for background readings, and
the dye content of the extracts was calculated from a standard
curve  of  Evans  blue  in  formamide.  Blood-retinal  barrier
breakdown was calculated using the following equation:
(µg of Evans blue)( time-averaged µg of Evans blue)/
(retinal wet weight in g)(µl of plasma x h of circulation)
The results were expressed as µl of plasma x retinal wet
wt−1 (g) x h−1.
Statistical analysis: The results were expressed as the
means±standard deviation or standard error of measurement
as indicated. Comparisons between groups were done using
ANOVA  followed  by  Fisher’s  protected  least-significant
difference test. All comparisons were done using the StatView
statistics  software  for  Macintosh,  with  a  value  of  p<0.05
indicating significance.
RESULTS
SHR rats are normotensive when they are 4 weeks old, but are
fully hypertensive by the time they are 12 weeks old. We used
both  age  groups  because  they  allowed  us  to  assess  the
contribution of the genetics of hypertension (4-week-old rats)
and the influence of genetics plus hypertension per se (12-
week-old  rats)  on  retinal  abnormalities.  As  previously
demonstrated by our group and others, the systolic blood
pressure (SBP) in 4-week-old SHR was significantly higher
than in WKY, although still within the normal range (Table
1). The SBP of 12-week-old SHR was significantly higher
(p=0.0001)  than  that  of  age-matched  WKY  (Table  1).
Bodyweight was lower, and blood glucose levels were higher
in diabetic rats than in their respective controls at both ages
(p=0.0001; Table 1).
Cells with progenitor characteristics in adult rat retina:
BrdU-positive-stained cells were rare but clearly identifiable
in  retinal  sections  of  adult  rats  (Figure  1A,B).  The
proliferating  retinal  cells  of  adult  rats  were  characterized
further by using specific cell markers, including GFAP, the
tyrosine-kinase  receptor  Flk1,  the  intermediate  filament
protein nestin, and PKC-α. BrdU and GFAP colocalized in
cells of the ganglion cell layer, suggesting that they may
represent  glial  cells  in  proliferation  (Figure  2A,B).  Other
BrdU-positive cells were also colabeled with nestin (Figure
2C), an intermediate filament structural protein expressed in
primitive neural tissue. The detection of this protein in the
inner nuclear and ganglion cell layers suggested the presence
of neural progenitor cells. Figure 2D shows a PKC-α-positive
cell in the outer nuclear layer that was also positive for BrdU.
In this case, cellular maturation involved a bipolar–amacrine
neural cell. The elongated BrdU-positive cells in the inner
nuclear layer reacted strongly with antibody against Flk-1
(Figure  2E),  a  surface  receptor  protein  characteristic  of
endothelial cells in cell cycle progression. These findings
indicate that adult rat retina contains different populations of
replicating cells with characteristics of glial or endothelial
cells. The detection of cells that coexpressed BrdU and nestin
or PKC-α suggests that subpopulations of replicating cells
may differentiate into neural cell subtypes.
Diabetes decreases the number of progenitor cells only
in retina from 12-week-old SHR: The total number of BrdU-
positive retinal cells in 12-week-old rats was significantly
higher  in  hypertensive  SHR  than  in  normotensive  WKY
(9.5±4.0 versus 1.2±0.4 positive retinal cells; p=0.01). After
15 days of diabetes mellitus, there was a significant decrease
in the number of these cells only in SHR (0.2±0.2 positive
retinal cells; p=0.007; Figure 3). In contrast, in 4-week-old
SHR and WKY rats, the number of proliferating cells was
similar in all groups (4.5±0.5 for control WKY versus 2.8±0.4
for diabetic WKY versus 3.4±0.4 for control SHR versus
4.0±0.5 for diabetic SHR BrdU-positive cells (p>0.05).
TUNEL staining is unaltered by rat strain, animal age,
or  short-term  diabetes:  The  number  of  TUNEL-positive
retinal cells in 4-week-old rats (SHR and WKY) was 3.2±2.8
Figure  3.  Total  number  of  BrdU-positive  cells  counted  in  eight
random retinal sections from 12-week-old rats. See Methods for
further details. The results are expressed as the mean±SEM; asterisk
(*) is p=0.02 versus CT- spontaneously hypertensive rats (SHR). The
number of BrDU positive cells present in retina from WKY rats is
very  low  and  do  not  change  according  to  experiment  condition
(presence of experimental diabetes); by contrast in SHR rats, it is
observed a higher number of these BrDU cells in retina and the
induction of diabetes dramatically reduced this number abbreviations
used are as follows: control WKY (CT-WKY), diabetic WKY (DM-
WKY), control SHR (CT-SHR), and diabetic SHR (DM-SHR).
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1685positive cells per retinal section in control WKY rats. This
number did not differ significantly from the 2.0±2.7 positive
cells per retinal section seen in diabetic WKY rats or the
2.0±2.0 and 0.9±0.8 positive cells per retinal section seen in
control and diabetic SHR, respectively. The rates of apoptosis
in retinal tissue in 12-week-old rats were also similar among
the  groups  (1.2±1.3  for  control  WKY  versus  1.9±2.7  for
diabetic WKY versus 1.6±1.7 control SHR versus 1.1±0.1 for
diabetic positive cells/retinal section, p<0.05). Hence, in eight
retinal sections, the number of TUNEL-positive cells was 9.6
for control WKY, 15.2 for diabetic WKY, 12.8 for control
SHR, and 8.8 for diabetic SHR.
Since diabetes and hypertension influenced the number
of  BrdU-positive  cells  only  in  12-week-old  rats,  all
subsequent experiments were done only 12-week-old rats.
To investigate a potential role for cell cycle regulatory
proteins in the reduction in BrdU-positive retinal cells in 12-
week-old  diabetic  SHR,  we  examined  the  expression  of
p27Kip1.  Immunohistochemistry  revealed  a  heterogeneous
distribution for p27Kip1 in the retinal cell layers, with greater
positivity in the ganglion cell layer (Figure 4A). There was a
significant increase in p27Kip1 protein positivity in this layer
in diabetic rats (1.5±1 in control WKY versus 2.5±0.5 in
diabetic WKY, and 1.5±1.5 in control SHR versus 2.5±1 in
diabetic  SHR  positive  score,  p=0.05;  Figure  4B).
Interestingly,  there  was  a  significant  increase  in  p27Kip1
protein in the inner nuclear layer only in diabetic SHR rats
(0.7±0.6  versus  1.6±0.4  positive  score  for  control  versus
diabetic SHR, p=0.02; Figure 4C). The increase in p27Kip1
expression in diabetic WKY, was not significant (0.9±0.5 and
1.6±0.5 positive score for normal and diabetic WKY; Figure
4C).  The  accumulation  of  p27Kip1  in  retinal  tissue  is
accompanied by increased fibronectin expression in diabetic
hypertensive rats.
To  identify  factors  potentially  involved  in  the
pathogenesis of diabetic retinopathy, we examined the retinal
expression of fibronectin, an extracellular matrix component
associated with functional properties of the inner blood-retinal
barrier. Western blot analysis of total retinal lysates revealed
a significant increase in fibronectin expression in diabetic
SHR  compared  with  control  SHR  (p=0.04)  or  diabetic
(p=0.03) and control WKY (p=0.009; Figure 5). The enhanced
expression of p27Kip1 and fibronectin reflected a generalized
response to hyperglycemia in target organs such as the kidney.
This  is  the  first  demonstration  of  an  association  between
increased expression of p27Kip1 and fibronectin accumulation
in retinal tissue, and could contribute to thickening of the
retinal capillary basement membrane seen in diabetic retina.
The expression of retinal GFAP is unaltered in SHR or
WKY rats: The retinal expression of GFAP in total retinal
lysates, as evaluated by western blotting, was used as an
indicator of glial cell reactivity. This expression did not differ
between 345 control SHR (5.2±1.4 arbitrary units ) and WKY
rats (4.5±0.5 arbitrary units), nor was it significantly altered
by 15 days of diabetes mellitus (4.5±0.5 for diabetic WKY
and 4.4±0.8 arbitrary units for diabetic SHR; Figure 6)
VEGF expression is enhanced in diabetic SHR after 15
days of diabetes mellitus: There was a significant increase in
the retinal expression of VEGF only in diabetic SHR (0.9±0.1
arbitrary units versus 1.1±0.1 arbitrary units for diabetic WKY
and  0.8±0.1  arbitrary  units  for  control  SHR  and  1.3±0.2
arbitrary units for diabetic SHR, p=0.02) (Figure 7).
Blood-retinal barrier breakdown occurs only in diabetic
hypertensive  rats:  The  extent  of  blood-retinal  barrier
breakdown, estimated by the extravasation of Evans blue dye,
Figure 4. Retinal expression of p27Kip1
in  retina  evaluated  through
immunohystochemistry  assay.  In  (A),
we  can  see  a  representative
immunohistochemical  staining  for
p27Kip1 in retina of control and diabetic
Wistar  Kyoto  (WKY)  rats  and
spontaneously hypertensive rats (SHR).
The brownish color represents staining
for p27Kip1, and the blue color represents
the  staining  of  retinal  tissue  with
hematoxylin.  Original  magnification
1000x, the bar in the figure represents a
scale of 50µm. The graphs represents
the  score  of  positivity  of  p27Kip1  in
retinal slides expressed by mean±SD in
ganglion cell (B) and inner nuclear (C)
layers. Asterisk (*) is p=0.05 versus CT-
WKY and CT-SHR, and dagger (†) is
p=0.02 versus CT-SHR.
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1686was similar in control and diabetic WKY rats (11.4±1.5 for
control WKY and 10.3±1.3 μg plasma x g retinal wet wt-1 x
h-1 for diabetic WKY; n=5 rats). In contrast, there was a
significant  increase  in  retinal  capillary  permeability  in
diabetic SHR compared with control SHR (8.6±0.7 for control
SHR and 17.4±4.6 for diabetic SHR μg plasma x retinal wet
wt-1xh-1; p=0.01, n=5 rats; Figure 8).
DISCUSSION
The results of this study show that the adult rat retina contains
a small number of BrdU-positive cells that also express glial,
neural, and endothelial progenitor cell markers. The number
of these cells was higher in hypertensive rats but was markedly
reduced by the concomitant presence of hypertension and
diabetes.  The  greater  expression  of  the  Cdk  inhibitor,
p27Kip1, probably accounts for the reduction in the number of
proliferating cells in diabetic retina. Additionally, diabetic
hypertensive rats with a reduction in the number of BrdU-
positive cells and enhanced p27Kip1 expression also displayed
classic  characteristics  of  early  diabetic  retinal  disease:
enhanced  fibronectin  and  VEGF  expression  and  greater
blood-retinal  barrier  breakdown.  These  observations—i.e.,
cell  cycle  withdrawal  and  enhanced  production  of
extracellular matrix and VEGF expression—could provide a
basis for a new understanding of the mechanisms involved in
the pathogenesis of diabetic retinopathy.
It  is  known  that  SHR  rats  display  innate  abnormal
endothelial  function  associated  with  eNOS  compensatory
Figure 5. Western blot assay to access the retinal expression of
fibronectin. A: The membranes were incubated with antibody against
glial fibrillar acidic protein in total retinal lysates. B: Band densities
(ratio of fibronectin to β actin) expressed in arbitrary densitometric
units.  The  columns  are  the  mean±SD  of  five  independent
experiments.
activity and increased nitric oxide production [35]. Evidence
is accumulating that implicates oxygen free radical formation
and  N-methyl-D-aspartate  (NMDA)-receptor-mediated
toxicity  in  the  pathophysiology  of  ischemic  retinal  injury
[36,37]. These two mechanisms are linked by nitric oxide.
NMDA-receptor  activation  generates  nitric  oxide,  which
reacts  with  superoxide  to  form  toxic  species  such  as
peroxynitrite.  Neuropeptide  Y  (NPY)  is  a  36  amino  acid
peptide widely present in the central nervous system including
the retina. NPY was recently found to stimulate retinal neural
cell  proliferation  mediated  through  nitric  oxide-cyclic
guanosine monophosphate (GMP) and extracellular signal-
regulated kinases (ERK) 1/2 pathways [38]. These results
suggest that the increased retinal cell proliferation observed
in SHR rats may be due to activation of NPY through nitric
oxide-cyclic GMP and ERK 1/2 pathways. Previous data from
other cell types of SHR also demonstrated that mesangial cells
have a higher proliferation rate in vitro than control WKY
mesangial  cells  [39],  suggesting  that  the  genetics  of
hypertension may contribute to this phenotype.
The changes described for diabetic hypertensive SHR
were not associated with the toxicity of streptozotocin for two
reasons: 1) they occurred in the retina of diabetic hypertensive
SHR but not in normotensive diabetic WKY rats; and 2) they
were absent in diabetic WKY and SHR rats rendered diabetic
at four weeks of age. These changes are also not attributable
to differences in metabolic control, because the blood glucose
levels were similar in both diabetic groups.
Figure 6. Retinal expression of glial fibrillar acidic protein assayed
by western blot. A: The membranes were incubated with antibody
against glial fibrillar acidic protein (GFAP) in total retinal lysates.
The columns represent the band densities (ratio of GFAP to β-actin)
expressed  in  arbitrary  densitometric  units.  Mean±SD  of  five
independent experiments. B: Band densities (ratio of GFAP to β-
actin) expressed in arbitrary densitometric units. The used symbols
are CT-WKY for control WKY, DM-WKY for diabetic WKY, CT-
SHR for control SHR and DM-SHR for diabetic SHR.
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1687The presence of neuronal progenitor cells in human retina
has recently been demonstrated. It was suggested that these
cells  may  potentially  replace  neurons  and  photoreceptors
[40]. The BrdU-positive retinal cells seen in the present study
were  not  completely  characterized.  However,  their
proliferative capacity and their colocalization with antigens
of neural, glial, and endothelial origin suggest multipotent
properties—i.e., they may represent progenitor cells.
Not  all  dividing  cells  in  the  retina  are  progenitors.
Numerous studies have sought to identify neural progenitor
cells.  The  intermediate  filament  protein  nestin  has  a
widespread, early expression in the developing retina and
central nervous system and is one of the best-characterized
protein  markers  for  immature  neural  cells  [41,42].  The
coexpression of nestin with other developmental markers,
such as the incorporation of BrdU (such as that seen in the
present study) strongly suggests that the cells involved are
immature.  In  addition  to  nestin,  we  also  observed
immunostaining for PKC-α (a bipolar–amacrine cell marker)
in BrdU-positive cells in the retina. The coexpression of BrdU
and nestin or BrdU and PKC-α was also seen.
Figure 7. Retinal expression of vascular endothelial growth factor
(VEGF) was accessed by western blot assay. In A, the membranes
were incubated with antibody against VEGF in total retinal lysates.
B: The graph display the band densities (ratio of VEGF to β actin)
expressed in arbitrary densitometric units. The columns are the mean
±SD of four experiments. The used symbols are CT-WKY for control
WKY, DM-WKY for diabetic WKY, CT-SHR for control SHR and
DM-SHR for diabetic SHR. Asterisk (*) is p=0.02 versus other
groups.
The cyclin kinase inhibitor p27Kip1 may be involved in
reducing the number of proliferating retinal cells. Levine et
al.  [28]  suggested  that  p27Kip1  is  part  of  the  molecular
mechanism that controls the decision of multipotency central
nervous system progenitor cells to withdraw from the cell
cycle. These authors also proposed that postmitotic Müller
glia have a novel, intrinsic requirement for p27Kip1 to maintain
their differentiated state. The heterogeneous distribution of
p27Kip 1 seen in retinal tissue, with greater expression in the
inner nuclear layer only in diabetic SHR, may contribute to
the different number of replicating cells in this group. Further
clarification  of  the  other  mechanisms  involved  in  what
prompts a replicating retinal cell to withdraw or continue in
the cycle when in the presence of diabetes and hypertension
is  beyond  the  scope  of  this  study  and  requires  a  new
experimental design.
In the present study, we did not detected an enhanced
apoptotic rate in retina from normotensive diabetic WKY and
hypertensive diabetic SHR rats, as reported by others. Thus,
for  example,  Gastinger  et  al.  [43]  reported  a  significant
increase in the apoptotic rate in retina from diabetic rats, based
on  the  number  of  TUNEL-positive  nuclei  seen  in  whole-
mounted retinas from Sprague-Dawley rats after two weeks
of streptozotocin-induced diabetes. The discrepancy between
our findings and the latter study may be related to differences
in rat strain and in the use of whole-mounted retina compared
to  retinal  cross-sections.  In  our  study,  the  retinas  of
diabetic=WKY  and  SHR  rats  after  12  weeks  of  diabetes
showed  a  significant  increase  in  the  number  of  TUNEL-
Figure 8. Retinal capillary permeability assessed by the Evans blue
method  in  control  and  diabetic  spontaneously  hypertensive  rats
(SHR)  and  Wistar  Kyoto  (WKY)  rats.  The  permeability  was
expressed in µl of plasma × g retinal wet wt−1 × h−1 wt. The results
are expressed as the mean±SD. The following abbreviations are in
effect:  control  WKY  (CT-WKY),  diabetic  WKY  (DM-WKY),
control SHR (CT-SHR), and diabetic SHR (DM-SHR).
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1688positive cells in the diabetic groups, particularly in diabetic
SHR rats (p=0,0003; unpublished).
Increased extracellular matrix protein production leading
to  structural  abnormalities  is  a  hallmark  of  diabetic
microangiopathy  and  has  been  demonstrated  in  all  target
organs of diabetic complications, including retina, kidney, and
heart [44,45]. Enhanced extracellular matrix protein synthesis
is instrumental in thickening of the basement membrane [16,
46]. Fibronectin is a major extracellular matrix component but
its overproduction may decrease the motility and replication
of many cells [46]. As revealed in the present study, retinal
tissue from diabetic WKY rats and nondiabetic SHR showed
enhanced  fibronectin  expression  in  total  retinal  lysates,
although this expression was not significantly different from
that in control WKY rats.
The  accumulation  of  fibronectin  in  retinal  tissue  is  a
classic  finding  encountered  early  in  the  pathogenesis  of
diabetic retinal disease and in the microcirculation in models
of hypertension [47-49]. Several studies have described the
accumulation  of  extracellular  matrix  in  target  organs  of
hypertensive  rats.  In  stroke-prone  SHR  there  is  enhanced
accumulation of extracellular matrix proteins in the cerebral
vasculature  [47,48].  Agabiti-Rosei  demonstrated  that
structural  and  functional  changes  in  the  microcirculation
during  arterial  hypertension,  e.g.,  remodeling  of  the
extracellular  matrix  and  accumulation  of  collagen  and
fibronectin, were associated with several neurohumoral and
hormonal factors [49]. Hence, the similar extracellular protein
accumulation  seen  here  between  diabetic  WKY  rats  and
nondiabetic  SHR  may  be  the  result  of  either  diabetes  or
hypertension alone.
The induction of diabetes in SHR leads to a reduction in
renal  cell  replication  with  concomitant  overexpression  of
p27Kip1 [14]. p27Kip1-deficient mice do not develop the classic
features of diabetic nephropathy such as renal hypertrophy,
glomerular expression of fibronectin, and albuminuria, all of
which  are  marked  in  wild-type  mice  [50].  This  finding
suggests that modulation of p27Kip1 function may ameliorate
diabetic nephropathy. The effect of a reduction in p27Kip1
expression on diabetic retinopathy remains to be elucidated.
In conclusion, the combination of genetic hypertension
and  experimental  diabetes  markedly  reduced  retinal  cell
proliferation. This reduction was associated with enhanced
p27Kip1, fibronectin, and VEGF retinal expressions and greater
blood-retinal  barrier  breakdown.  Additional  studies  are
required to clarify the mechanisms by which these cellular
changes contribute to the structural abnormalities associated
with the early pathogenesis of diabetic retinopathy.
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